StockData
Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc. (AVTX) stock

AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$6.70−0.43 (-6.03%)

Close on Nov 18, 2026Market cap $359.32MP/E –Yield –

Avalo Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Avalo Therapeutics's market cap was $450.18M on Nov 11, 2026, against $338.73M a year earlier. Over the last 5 years it ranged from $1.40M to $1.02B, with a median of $52.15M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$450.18M+39.1%
2025Dec 31, 2025$323.75M+350.0%
2024Dec 31, 2024$71.94M+886.2%
2023Dec 29, 2023$7.29M-84.6%
2022Dec 30, 2022$47.41M-75.2%
2021Dec 31, 2021$190.79M-3.4%
2020Dec 31, 2020$197.59M-16.8%
2019Dec 31, 2019$237.56M+80.9%
2018Dec 31, 2018$131.30M+57.6%
2017Dec 29, 2017$83.31M+943.6%
2016Dec 30, 2016$7.98M+266.1%
2015Dec 31, 2015$2.18M–

More Avalo Therapeutics figures

See a number that looks wrong?